Cancer Treatment Holdings Inc (CTHZ.PK) Quote| Reuters.com
Edition:
United States

Cancer Treatment Holdings Inc (CTHZ.PK)

CTHZ.PK on OTC Markets Group

0.10USD
19 May 2016
Change (% chg)

-- (--)
Prev Close
$0.10
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
--
52-wk High
--
52-wk Low
--

CTHZ.PK

Chart for CTHZ.PK

About

Cancer Treatment Holdings, Inc. provides specialty out-patient services. The Company is engaged in the ambulatory treatment of cancer using a variety of modalities, including radiation therapy, bone marrow transplantation, home infusion and home health care.
No analyst recommendations are available for CTHZ.PK.

Overall

Beta: --
Market Cap(Mil.): $0.33
Shares Outstanding(Mil.): 3.34
Dividend: --
Yield (%): --

Financials

  CTHZ.PK Industry Sector
P/E (TTM): -- 55.80 36.15
EPS (TTM): -0.83 -- --
ROI: -39.24 5.38 14.31
ROE: -59.07 8.52 15.51

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : ValuEngine, Inc.
$49.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.